ClinicalTrials.Veeva

Menu

Markers of Atrial Cardiopathay

A

Assiut University

Status

Enrolling

Conditions

Atrial Cardiopathy

Treatments

Diagnostic Test: Holter ,Echo , Speckle tracking echocardiography

Study type

Observational

Funder types

Other

Identifiers

NCT05623969
atrial cardiopathay

Details and patient eligibility

About

Marker of atrial cardiopathay as apredictor value of ischemic stroke

Full description

detection of the presence of atrial dysfunction or atrial cardiopathy and its degree among patients complaining of palpitation, with a one-year follow-up for any cardioembolic events (stroke /TIA).

Enrollment

30 estimated patients

Sex

All

Ages

17 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients complaining of palpitation referred for Holter monitoring

Exclusion criteria

  • • Valvular AF, moderate to severe mitral/ tricuspid/ aortic stenosis or regurgitation.

    • Recent myocardial infarction within 3 months.
    • Acute pulmonary embolism.
    • Newly onset AF during or shortly after cardiac surgery.
    • Specific type of cardiomyopathy such as cardiac amyloidosis, obstructive hypertrophic cardiomyopathy.

Decompensation stage of organ failure

Trial contacts and locations

1

Loading...

Central trial contact

Mariam zarief farhan, resident; Amr Ahmed Aly Youssef, professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems